Health
Cleavage site recognition by SARS-CoV-2 main protease as new antiviral drug target – News-Medical.Net
Many research groups have and are investigating main protease inhibitors as antiviral drugs, and in a paper recently uploaded to the bioRxiv* preprint server, a…
The main protease of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) cleaves the proteins produced by the virus at various stages of replication and maturation. Highly conserved across coronaviruses due to the essential functional role of the enzyme, it also makes an appealing drug target.
Many research groups have and are investigating main protease inhibitors as antiviral drugs, and in a paper recently uploaded to the bioRxiv* preprint server, a team of researchers examine the crystal…
-
General22 hours agoCoalition seeks to rebuild ties with Indian community
-
Business22 hours agoHow to retire in your 50s with ASX shares
-
Noosa News22 hours agoGold Coast fans ‘galvanized’ behind the Suns ahead of AFL QClash semifinal
-
General22 hours agoFood and garden organic waste bin system on verge of collapse across WA’s South West